×




Alnylam Pharmaceuticals: Building Value from the IP Estate (B) Net Present Value (NPV) / MBA Resources

Introduction to Net Present Value (NPV) - What is Net Present Value (NPV) ? How it impacts financial decisions regarding project management?

NPV solution for Alnylam Pharmaceuticals: Building Value from the IP Estate (B) case study


At Oak Spring University, we provide corporate level professional Net Present Value (NPV) case study solution. Alnylam Pharmaceuticals: Building Value from the IP Estate (B) case study is a Harvard Business School (HBR) case study written by Vicki L. Sato, Willy Shih, Matt Higgins. The Alnylam Pharmaceuticals: Building Value from the IP Estate (B) (referred as “Sirna Alnylam” from here on) case study provides evaluation & decision scenario in field of Technology & Operations. It also touches upon business topics such as - Value proposition, Strategic planning.

The net present value (NPV) of an investment proposal is the present value of the proposal’s net cash flows less the proposal’s initial cash outflow. If a project’s NPV is greater than or equal to zero, the project should be accepted.

NPV = Present Value of Future Cash Flows LESS Project’s Initial Investment






Case Description of Alnylam Pharmaceuticals: Building Value from the IP Estate (B) Case Study


The leader of a pioneering biotech company in the siRNA space weighs his options for scaling production capacity in advance of an anticipated commercial launch. Operational complexity and relative merits of in-house manufacturing versus a contractor model are discussed.


Case Authors : Vicki L. Sato, Willy Shih, Matt Higgins

Topic : Technology & Operations

Related Areas : Strategic planning




Calculating Net Present Value (NPV) at 6% for Alnylam Pharmaceuticals: Building Value from the IP Estate (B) Case Study


Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 6 %
Discounted
Cash Flows
Year 0 (10008994) -10008994 - -
Year 1 3451415 -6557579 3451415 0.9434 3256052
Year 2 3974274 -2583305 7425689 0.89 3537090
Year 3 3939168 1355863 11364857 0.8396 3307401
Year 4 3228225 4584088 14593082 0.7921 2557057
TOTAL 14593082 12657600




The Net Present Value at 6% discount rate is 2648606

In isolation the NPV number doesn't mean much but put in right context then it is one of the best method to evaluate project returns. In this article we will cover -

Different methods of capital budgeting


What is NPV & Formula of NPV,
How it is calculated,
How to use NPV number for project evaluation, and
Scenario Planning given risks and management priorities.




Capital Budgeting Approaches

Methods of Capital Budgeting


There are four types of capital budgeting techniques that are widely used in the corporate world –

1. Profitability Index
2. Payback Period
3. Internal Rate of Return
4. Net Present Value

Apart from the Payback period method which is an additive method, rest of the methods are based on Discounted Cash Flow technique. Even though cash flow can be calculated based on the nature of the project, for the simplicity of the article we are assuming that all the expected cash flows are realized at the end of the year.

Discounted Cash Flow approaches provide a more objective basis for evaluating and selecting investment projects. They take into consideration both –

1. Timing of the expected cash flows – stockholders of Sirna Alnylam have higher preference for cash returns over 4-5 years rather than 10-15 years given the nature of the volatility in the industry.
2. Magnitude of both incoming and outgoing cash flows – Projects can be capital intensive, time intensive, or both. Sirna Alnylam shareholders have preference for diversified projects investment rather than prospective high income from a single capital intensive project.






Formula and Steps to Calculate Net Present Value (NPV) of Alnylam Pharmaceuticals: Building Value from the IP Estate (B)

NPV = Net Cash In Flowt1 / (1+r)t1 + Net Cash In Flowt2 / (1+r)t2 + … Net Cash In Flowtn / (1+r)tn
Less Net Cash Out Flowt0 / (1+r)t0

Where t = time period, in this case year 1, year 2 and so on.
r = discount rate or return that could be earned using other safe proposition such as fixed deposit or treasury bond rate. Net Cash In Flow – What the firm will get each year.
Net Cash Out Flow – What the firm needs to invest initially in the project.

Step 1 – Understand the nature of the project and calculate cash flow for each year.
Step 2 – Discount those cash flow based on the discount rate.
Step 3 – Add all the discounted cash flow.
Step 4 – Selection of the project

Why Technology & Operations Managers need to know Financial Tools such as Net Present Value (NPV)?

In our daily workplace we often come across people and colleagues who are just focused on their core competency and targets they have to deliver. For example marketing managers at Sirna Alnylam often design programs whose objective is to drive brand awareness and customer reach. But how that 30 point increase in brand awareness or 10 point increase in customer touch points will result into shareholders’ value is not specified.

To overcome such scenarios managers at Sirna Alnylam needs to not only know the financial aspect of project management but also needs to have tools to integrate them into part of the project development and monitoring plan.

Calculating Net Present Value (NPV) at 15%

After working through various assumptions we reached a conclusion that risk is far higher than 6%. In a reasonably stable industry with weak competition - 15% discount rate can be a good benchmark.



Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 15 %
Discounted
Cash Flows
Year 0 (10008994) -10008994 - -
Year 1 3451415 -6557579 3451415 0.8696 3001230
Year 2 3974274 -2583305 7425689 0.7561 3005122
Year 3 3939168 1355863 11364857 0.6575 2590067
Year 4 3228225 4584088 14593082 0.5718 1845748
TOTAL 10442168


The Net NPV after 4 years is 433174

(10442168 - 10008994 )








Calculating Net Present Value (NPV) at 20%


If the risk component is high in the industry then we should go for a higher hurdle rate / discount rate of 20%.

Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 20 %
Discounted
Cash Flows
Year 0 (10008994) -10008994 - -
Year 1 3451415 -6557579 3451415 0.8333 2876179
Year 2 3974274 -2583305 7425689 0.6944 2759913
Year 3 3939168 1355863 11364857 0.5787 2279611
Year 4 3228225 4584088 14593082 0.4823 1556821
TOTAL 9472524


The Net NPV after 4 years is -536470

At 20% discount rate the NPV is negative (9472524 - 10008994 ) so ideally we can't select the project if macro and micro factors don't allow financial managers of Sirna Alnylam to discount cash flow at lower discount rates such as 15%.





Acceptance Criteria of a Project based on NPV

Simplest Approach – If the investment project of Sirna Alnylam has a NPV value higher than Zero then finance managers at Sirna Alnylam can ACCEPT the project, otherwise they can reject the project. This means that project will deliver higher returns over the period of time than any alternate investment strategy.

In theory if the required rate of return or discount rate is chosen correctly by finance managers at Sirna Alnylam, then the stock price of the Sirna Alnylam should change by same amount of the NPV. In real world we know that share price also reflects various other factors that can be related to both macro and micro environment.

In the same vein – accepting the project with zero NPV should result in stagnant share price. Finance managers use discount rates as a measure of risk components in the project execution process.

Sensitivity Analysis

Project selection is often a far more complex decision than just choosing it based on the NPV number. Finance managers at Sirna Alnylam should conduct a sensitivity analysis to better understand not only the inherent risk of the projects but also how those risks can be either factored in or mitigated during the project execution. Sensitivity analysis helps in –

What are the uncertainties surrounding the project Initial Cash Outlay (ICO’s). ICO’s often have several different components such as land, machinery, building, and other equipment.

Understanding of risks involved in the project.

What are the key aspects of the projects that need to be monitored, refined, and retuned for continuous delivery of projected cash flows.

What can impact the cash flow of the project.

What will be a multi year spillover effect of various taxation regulations.

Some of the assumptions while using the Discounted Cash Flow Methods –

Projects are assumed to be Mutually Exclusive – This is seldom the came in modern day giant organizations where projects are often inter-related and rejecting a project solely based on NPV can result in sunk cost from a related project.

Independent projects have independent cash flows – As explained in the marketing project – though the project may look independent but in reality it is not as the brand awareness project can be closely associated with the spending on sales promotions and product specific advertising.






Negotiation Strategy of Alnylam Pharmaceuticals: Building Value from the IP Estate (B)

References & Further Readings

Vicki L. Sato, Willy Shih, Matt Higgins (2018), "Alnylam Pharmaceuticals: Building Value from the IP Estate (B) Harvard Business Review Case Study. Published by HBR Publications.


Enteq Upstream SWOT Analysis / TOWS Matrix

Energy , Oil Well Services & Equipment


L’Occitane International SWOT Analysis / TOWS Matrix

Consumer/Non-Cyclical , Personal & Household Prods.


Guangdong Land SWOT Analysis / TOWS Matrix

Capital Goods , Construction Services


Zhangzidao Fish A SWOT Analysis / TOWS Matrix

Consumer/Non-Cyclical , Fish/Livestock


Safeland SWOT Analysis / TOWS Matrix

Capital Goods , Construction Services


Aecon Group Inc. SWOT Analysis / TOWS Matrix

Capital Goods , Construction Services


Twintek Investment SWOT Analysis / TOWS Matrix

Capital Goods , Construction - Raw Materials


Hubei Mailyard Share SWOT Analysis / TOWS Matrix

Consumer Cyclical , Apparel/Accessories


Tibet Aim Pharm SWOT Analysis / TOWS Matrix

Healthcare , Biotechnology & Drugs